Adelaide Research & Scholarship: Search

Search

Results 1-10 of 18 (Search time: 0.002 seconds).

previous
1
2
next

Item hits:

Preview	Issue Date	Title	Author(s)
	2014	High-intensity statin therapy alters the natural history of diabetic coronary atherosclerosis: Insights from SATURN	Stegman, B.; Puri, R.; Cho, L.; Shao, M.; Ballantyne, C.; Barter, P.; Chapman, M.; Erbel, R.; Libby, P.; Raichlen, J.; Uno, K.; Kataoka, Y.; Nissen, S.; Nicholls, S.
	2014	Antiatherosclerotic effects of long-term maximally intensive statin therapy after acute coronary syndrome: insights from study of coronary atheroma by intravascular ultrasound: effect of rosuvastatin versus atorvastatin	Puri, R.; Nissen, S.; Shao, M.; Ballantyne, C.; Barter, P.; Chapman, M.; Erbel, R.; Libby, P.; Raichlen, J.; Uno, K.; Kataoka, Y.; Nicholls, S.
	2018	Association of lipoprotein(a) with risk of recurrent ischemic events following acute coronary syndrome: analysis of the dal-outcomes randomized clinical trial	Schwartz, G.; Ballantyne, C.; Barter, P.; Kallend, D.; Leiter, L.; Leitersdorf, E.; McMurray, J.; Nicholls, S.; Olsson, A.; Shah, P.; Tardif, J.-C.; Kittelson, J.
	2015	Assessment of the clinical effects of cholesteryl ester transfer protein inhibition with evacetrapib in patients at high-risk for vascular outcomes: rationale and design of the ACCELERATE trial	Nicholls, S.; Lincoff, A.; Barter, P.; Brewer, H.; Fox, K.; Gibson, C.; Grainger, C.; Menon, V.; Montalescot, G.; Rader, D.; Tall, A.; McErlean, E.; Riesmeyer, J.; Vangerow, B.; Ruotolo, G.; Weerakkody, G.; Nissen, S.
	2013	Achievement of 2011 European low-density lipoprotein cholesterol (LDL-C) goals of either <70 mg/dl or ≥50% reduction in high-risk patients: results from VOYAGER	Karlson, B.; Nicholls, S.; Lundman, P.; Palmer, M.; Barter, P.
	2013	Factors underlying regression of coronary atheroma with potent statin therapy	Puri, R.; Nissen, S.; Ballantyne, C.; Barter, P.; Chapman, M.; Erbel, R.; Libby, P.; Raichlen, J.; St. John, J.; Wolski, K.; Uno, K.; Kataoka, Y.; Nicholls, S.
	2013	Achievement of LDL-C goals depends on baseline LDL-C and choice and dose of statin: An analysis from the VOYAGER database	Palmer, M.; Nicholls, S.; Lundman, P.; Barter, P.; Karlson, B.
	2013	C-reactive protein, but not low-density lipoprotein cholesterol levels, associate with coronary atheroma regression and cardiovascular events after maximally intensive statin therapy	Puri, R.; Nissen, S.; Libby, P.; Shao, M.; Ballantyne, C.; Barter, P.; Chapman, M.; Erbel, R.; Raichlen, J.; Uno, K.; Kataoka, Y.; Nicholls, S.
	2013	Coronary atheroma volume and cardiovascular events during maximally intensive statin therapy	Puri, R.; Nissen, S.; Shao, M.; Ballantyne, C.; Barter, P.; Chapman, M.; Erbel, R.; Libby, P.; Raichlen, J.; Uno, K.; Kataoka, Y.; Nicholls, S.
	2016	Doses of rosuvastatin, atorvastatin and simvastatin that induce equal reductions in LDL-C and non-HDL-C: results from the VOYAGER meta-analysis	Karlson, B.; Palmer, M.; Nicholls, S.; Lundman, P.; Barter, P.